Jubilant Pharmova informs about outcome of board meeting

31 Oct 2025 Evaluate
Pursuant to the provisions of Regulation 33 read with Regulation 30 and other applicable provisions of the Listing Regulations, as amended, Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held today i.e. on Friday, October 31, 2025, at 11:40 AM that concluded at 12:50 PM, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025. Pursuant to the applicable provisions of the Listing Regulations, they enclosed the following: 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2025; 2. Limited Review Report on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; The above mentioned documents will be simultaneously posted on the Company's website at www.jubilantpharmova.com. 

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

1078.00 8.80 (0.82%)
05-Dec-2025 14:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.80
Dr. Reddys Lab 1275.10
Cipla 1525.60
Zydus Lifesciences 933.55
Lupin 2101.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×